Loading company…
Bangalore-based Stelis Biopharma is a contract development and manufacturing organization that specializes in complex injectable drugs.
Its OneSource services cover sterile liquids, lyophilized vials, prefilled syringes and dry powder injections, plus drug-device assembly, mainly for pharmaceutical companies in North America and Europe. Founded in 2012 in Bangalore, India, the company has raised USD 85.00 mn across rounds, including a Series B of USD 40.00 mn on March 19, 2021 led by TPG, with Mankekar Family Office, Route One Investment Company and Think Investment Management participating. Revenue for fiscal 2023 was USD 5.12 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in